Zobrazeno 1 - 10
of 363
pro vyhledávání: '"Hans, Garmo"'
Publikováno v:
European Urology Open Science, Vol 52, Iss , Pp 166-173 (2023)
Background: Regional differences in active surveillance (AS) uptake for prostate cancer (PC) illustrate an inequality in treatment strategies. Objective: To examine the association between regional differences in AS uptake and transition to radical t
Externí odkaz:
https://doaj.org/article/c975b2b0ee304fdeb4d296212b990744
Autor:
Emma Söderberg, Fredrik Wärnberg, Anna-Karin Wennstig, Greger Nilsson, Hans Garmo, Lars Holmberg, Carl Blomqvist, Malin Sund, Charlotta Wadsten
Publikováno v:
Breast, Vol 73, Iss , Pp 103614- (2024)
Introduction: Observational studies suggest that breast conserving surgery (BCS) and radiotherapy (RT) offers superior survival compared to mastectomy. The aim was to compare patient and tumour characteristics in women with invasive breast cancer ≤
Externí odkaz:
https://doaj.org/article/6d06e232270a42e2a029300007185f00
Publikováno v:
PLoS ONE, Vol 19, Iss 1 (2024)
Externí odkaz:
https://doaj.org/article/bb9468a6470642309518fe9436f0c53a
Autor:
Eugenio Ventimiglia, Anna Bill-Axelson, Jan Adolfsson, Markus Aly, Martin Eklund, Marcus Westerberg, Pär Stattin, Hans Garmo
Publikováno v:
European Urology Open Science, Vol 44, Iss , Pp 46-51 (2022)
Background: Little is known about disease trajectories for men with castration-resistant prostate cancer (CRPC). Objective: To create a state transition model that estimates time spent in the CRPC state and its outcomes. Design, setting, and particip
Externí odkaz:
https://doaj.org/article/85d3a094259c49b2bb543a344ae02efc
Autor:
Magdalena Lycken, Oskar Bergengren, Linda Drevin, Hans Garmo, Marcus Westerberg, Elin Axén, Johan Stranne, Lars Holmberg, Anna Bill-Axelson
Publikováno v:
European Urology Open Science, Vol 41, Iss , Pp 81-87 (2022)
Background: Attempts to reduce prostate cancer (PC) mortality require an understanding of temporal changes in the characteristics of men with lethal PC. Objective: To describe the diagnostic characteristics of and time trends for a nationwide populat
Externí odkaz:
https://doaj.org/article/141e59a3db684f1991502da8c1034c20
Autor:
Oskar Bergengren, Helena Kaihola, Ann-Charlotte Borgefeldt, Eva Johansson, Hans Garmo, Anna Bill-Axelson
Publikováno v:
European Urology Open Science, Vol 38, Iss , Pp 25-31 (2022)
Background: Satisfaction with nurse-led follow-up among men with prostate cancer is high. However, it is unclear whether all men are satisfied or whether there are men who would benefit from being followed by a urologist or a nurse. Objective: To inv
Externí odkaz:
https://doaj.org/article/0c0be8bfc8474629a90424ccd642764f
Autor:
Yashar Khoshkar, Marcus Westerberg, Jan Adolfsson, Anna Bill‐Axelson, Henrik Olsson, Martin Eklund, Olof Akre, Hans Garmo, Markus Aly
Publikováno v:
BJUI Compass, Vol 3, Iss 2, Pp 173-183 (2022)
Abstract Objectives The objective of this study is to find clinical variables that predict the prognosis for men with castration‐resistant prostate cancer (CRPC) in a Swedish real‐life CRPC cohort, including a risk group classification to clarify
Externí odkaz:
https://doaj.org/article/ffef690841a74629b9214454386fd3cc
Publikováno v:
BMC Urology, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background Epidemiological data on anticoagulation for venous thromboembolism (VTE) in prostate cancer are sparse. We aimed to investigate associations between anticoagulation duration and risks of VTE recurrence after treatment cessation an
Externí odkaz:
https://doaj.org/article/1e963667535e4f41a88d0d4127aa4d16
Autor:
Mieke Van Hemelrijck, Eugenio Ventimiglia, David Robinson, Rolf Gedeborg, Lars Holmberg, Pär Stattin, Hans Garmo
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 22, Iss 1, Pp 1-20 (2022)
Abstract Introduction For clinical decision-making, an estimate of remaining lifetime is needed to assess benefit against harm of a treatment during the remaining lifespan. Here, we describe how to predict life expectancy based on age, Charlson Comor
Externí odkaz:
https://doaj.org/article/afafe7730b1244d9a1b61b959fbba258
Autor:
Mats Steinholtz Ahlberg, Hans-Olov Adami, Hans Garmo, Lars Holmberg, Anna Bill-Axelson, Ove Andren, Gunnar Steineck, Jan-Erik Johansson
Publikováno v:
BMJ Open, Vol 12, Iss 12 (2022)
Objective Although surveillance after radical prostatectomy routinely includes repeated prostate specific antigen (PSA)-testing for many years, biochemical recurrence often occurs without further clinical progression. We therefore hypothesised that f
Externí odkaz:
https://doaj.org/article/ae5c375486974379ae11a95bd7ac9f02